Artivion (AORT) vs SpyGlass Pharma (SGP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SpyGlass Pharma is the larger company by market cap ($1.02 billion vs $886.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | SGP |
|---|---|---|
| Share price | $18.16 | $30.43 |
| Market cap | $886.02M | $1.02B |
| 1-day change | -2.00% | -1.14% |
| YTD return | -60.18% | — |
| 1-year return | -59.76% | — |
| 5-year return | -0.82% | — |
| Forward P/E | 34.92 | — |
| EPS (TTM) | $-0.36 | $-2.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $441.33M | — |
| Revenue growth (YoY) | +13.59% | — |
| Net income (latest FY) | $9.77M | $-39.87M |
| Gross margin | 64.40% | — |
| Operating margin | 7.65% | — |
| Net margin | 2.21% | — |
| 52-week high | $48.25 | $39.92 |
| 52-week low | $18.12 | $17.06 |
| Distance from 52-week high | -62.36% | -23.77% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +111.84% | +53.37% |
| Average volume | 671.97K | 114.63K |
| Shares outstanding | 48.79M | 33.46M |
| Employees | 1,800 | 88 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Health Care · Medical/Dental Instruments · 1,800 employees
About SpyGlass Pharma
SGP stock →SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.
Health Care · Medical/Dental Instruments · 88 employees
AORT vs SGP FAQ
Which is bigger, Artivion or SpyGlass Pharma?
SpyGlass Pharma (SGP) is larger, with a market capitalization of $1.02B compared with $886.02M for Artivion (AORT).
Are Artivion and SpyGlass Pharma in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.